Description: Artemis Therapeutics, Inc., formerly New York Global Innovations Inc., seeks to offer alternatives to allergy medications. The Company provides various dietary and lifestyle guidelines, and also offers Lucidia and approximately six Chinese herb support formulas for purchase or prescription filling. The Company offers Artemis Allergy Relief Program, which is an educational resource center for health care practitioners, patients, and anyone suffering from seasonal, environmental or pet allergies. The program is a natural approach to allergy treatment or can be used alongside various therapies. The program provides various tools and natural medicinals to cultivate health and mitigate allergy symptoms. Artemis Allergy Treatment Program is intended for people suffering from seasonal allergies or yearlong allergies to pollens, animals, mold, dust, grasses, trees and hay fever.
Home Page: bmanuka.co.il
3 Eliezer Vardinon St.
Petach Tikva,
4959507
Israel
Phone:
646 233 1454
Officers
| Name | Title |
|---|---|
| Mr. Shimon Citron | CEO & Director |
| Mr. Haim Tabak | Consultant |
| Mr. David Dana | Chief Financial Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 50.5233 |
| Price-to-Sales TTM: | 861.5482 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |